View Press Releases
-
CloudLIMS Exhibits its Secure Medical and Healthcare LIMS @ 2022 AACC, Chicago
CloudLIMS is exhibiting @2022 AACC Annual Scientific Meeting & Clinical Lab Expo and showcasing its Medical & Healthcare LIMS at Booth 464 from July 26 - 28 in Chicago.
Jul 5, 2022
-
WHO calls for new innovations to tackle antimicrobial resistance crisis
With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. An innovation from UCL in London and developed by Canadian life sciences company, Ondine Biomedical, uses photodisinfection to kill infection-causing pathogens, including viruses, bacteria, and fungi.
Jul 5, 2022
-
DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400
DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
Jul 4, 2022
-
CD Formulation Enlarges Particulate Matter Testing Capability
-
A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer
-
3D Bioprinting Market Owing To Growth Within Biotechnology Sector from 2019 to 2028
The global 3D bioprinting market is segmented based on technology, material, application and geography. Based on technology, the market is categorized into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting and microextrusion 3D bioprinting.
Jul 3, 2022
-
BOC Sciences Highlighted Carbohydrates Harvest Admiring Fans at CPhI North America 2022
-
BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development
-
BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production
-
BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D
-
BOC Sciences Commitment at BIO 2022: From Concept to GMP Production
-
IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies
-
CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service
-
Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues
BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.
Jun 29, 2022
-
NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project
-
MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease
MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.
Jun 29, 2022
-
Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies
-
Saama Technologies Announces Appointment of New CEO Vivek Sharma
#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO
Jun 27, 2022
-
Kyruus Announces Paul Merrild as Company’s First President
Leadership Team Expansion Follows Year of Accelerated Growth
Jun 28, 2022
-
PHASTAR Names Chris Schoonmaker as Chief Operations Officer
PHASTAR Names Chris Schoonmaker as Chief Operations Officer London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.
Jun 28, 2022